Results 211 to 220 of about 83,464 (331)

Viral hemorrhagic fevers:(Week 15) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending April 11, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Current Topics of Progressive Cardiac Conduction Disease

Journal of Arrhythmia, Volume 42, Issue 3, June 2026.
Many genes and the protein cause PCCD. Mutation of NaV1.5 or CX40 cause isolated PCCD, but mutation of lamin A/C, emerin, or desmin lead to cardiomyopathy, and PCCD. Mutation of transcription factor NCX2‐5, and Tbx5 associated with atrial septal defect and abnormal development of conduction system.
Naokata Sumitomo, Hitoshi Mori, Takashi Kumamoto, Taisuke Ishikawa, Akiko Seki, Naomasa Makita, Jean‐Jacques Schott, Arthur A. M. Wilde   +7 more
wiley   +1 more source

Acute acalculous cholecystitis and dengue fever: a case report from Australia. [PDF]

Int J Surg Case Rep
Izwan S, Rumble W, Lyon M.
europepmc   +1 more source

Viral hemorrhagic fevers:(Week 14) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending April 4, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Significance and Usefulness of High‐Resolution 24‐h Electrocardiographic Parameters in Patients With Coronavirus Disease 2019 After Admission: A Prospective Cohort Study

Journal of Arrhythmia, Volume 42, Issue 3, June 2026.
In patients with coronavirus disease 2019 (COVID‐19) without an obvious cardiac disease, ambulatory electrocardiographic markers can be useful in assessing the risk of severe disease. Particularly, simultaneous positivity of late potential (LP) and T wave alternans (TWA) in patients with COVID‐19 was a poorer prognostic factor than LP or TWA alone ...
Motohiro Kimata, Kenichi Hashimoto, Naomi Harada, Yusuke Kawamura, Yoshifumi Kimizuka, Mayuko Kaneko, Nobuaki Kiriu, Yasumasa Sekine, Natsumi Iwabuchi, Tetsuro Kiyozumi, Susumu Matsukuma, Yuji Tanaka, Nobutaka Hirooka   +12 more
wiley   +1 more source

Correction: Development of a non-infectious control for viral hemorrhagic fever PCR assays. [PDF]

PLoS Negl Trop Dis
Knox MA, Bromhead C, Hayman DT.
europepmc   +1 more source

Viral hemorrhagic fevers:(Week 18) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending May 2, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First‐line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non‐comparative, Randomized Phase 2 Trial

MedComm, Volume 7, Issue 6, June 2026.
This phase II study explored the efficacy and safety of HAIC plus toripalimab in locally advanced HCC. The primary endpoint was the PFS rate at 6 months. The 6‐month PFS rate was 63.9% in the TorHAIC group and 61.1% in the SoraHAIC group. Treatment with the TorHAIC regimen resulted in a median OS of 20.9 months and a median PFS of 9.1 months.
Zhicheng Lai, Aojie Ge, Hanyue Ouyang, Zichao Wu, Yexing Huang, Qijiong Li, Li Xu, Binkui Li, Minshan Chen, Dongsheng Wen, Anna Kan, Ming Shi, Minke He   +12 more
wiley   +1 more source

Molecular and Serological Evaluation of Hantavirus in Wild Rodents in Kohgiluyeh and Boyer-Ahmad Province, Southwest of Iran. [PDF]

J Arthropod Borne Dis
Sarvari J, Sarkari B, Osooreh F, Fazlalipour M, Pouriayevali MH, Jalali T, Ranjbar MJ, Salehi-Vaziri M.   +7 more
europepmc   +1 more source

Viral hemorrhagic fevers (continued) (Week 37) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents week ending September 12, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core